Natural SIV Infection: Immunological Aspects

Models of Protection Against HIV/SIV

Volumn , Issue , 2012, Pages 47-79

  Jacquelin, Béatrice ^a   Zahn, Roland C ^b   Barré Sinoussi, Françoise ^a   Schmitz, Jörn E ^b   Kaur, Amitinder ^b   Müller Trutwin, Michaela C ^a  

^a INSTITUT PASTEUR   (France)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882895090     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-387715-4.00002-2     Document Type: Chapter

References (181)

1. Hirsch V.M., Olmsted R.A., Murphey-Corb M., Purcell R.H., Johnson P.R. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 1989, 339:389-392.
2. Keele B.F., Van Heuverswyn F., Li Y., Bailes E., Takehisa J., Santiago M.L., et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 2006, 313:523-526.
3. Van Heuverswyn F., Li Y., Neel C., Bailes E., Keele B.F., Liu W., et al. Human immunodeficiency viruses: SIV infection in wild gorillas. Nature 2006, 444:164.
4. Hahn B.H., Shaw G.M., De Cock K.M., Sharp P.M. AIDS as a zoonosis: Scientific and public health implications. Science 2000, 287:607-614.
5. VandeWoude S., Apetrei C. Going wild: Lessons from naturally occurring T-lymphotropic lentiviruses. Clin Microbiol Rev 2006, 19:728-762.
6. Van Heuverswyn F., Peeters M. The origins of HIV and implications for the global epidemic. Curr Infect Dis Rep 2007, 9:338.
7. Keele B.F., Jones J.H., Terio K.A., Estes J.D., Rudicell R.S., Wilson M.L., et al. Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature 2009, 460:515.
8. Ling B., Apetrei C., Pandrea I., Veazey R.S., Lackner A.A., Gormus B., et al. Classic AIDS in a sooty mangabey after an 18-year natural infection. J Virol 2004, 78:8902-8908.
9. Pandrea I., Onanga R., Rouquet P., Bourry O., Ngari P., Wickings E.J., et al. Chronic SIV infection ultimately causes immunodeficiency in African non-human primates. AIDS 2001, 15:2461-2462.
10. Traina-Dorge V., Blanchard J., Martin L., Murphey-Corb M. Immunodeficiency and lymphoproliferative disease in an African green monkey dually infected with SIV and STLV-I. AIDS Res Hum Retroviruses 1992, 8:97-100.
11. Chahroudi A., Meeker T., Lawson B., Ratcliffe S., Else J., Silvestri G. Mother-to-infant transmission of simian immunodeficiency virus is rare in sooty mangabeys and is associated with low viremia. J Virol 2011, 85:5757-5763.
12. Jolly C., Phillips-Conroy J.E., Turner T.R., Broussard S., Allan J.S. SIVagm incidence over two decades in a natural population of Ethiopian grivet monkeys (Cercopithecus aethiops aethiops). J Med Primatol 1996, 25:78-83.
13. Müller M.C., Barre-Sinoussi F. SIVagm: Genetic and biological features associated with replication. Front Biosci 2003, 8:d1170.
14. Nerrienet E., Amouretti X., Müller-Trutwin M.C., Poaty-Mavoungou V., Bedjebaga I., Nguyen H.T., et al. Phylogenetic analysis of SIV and STLV type I in mandrills (Mandrillus sphinx): Indications that intracolony transmissions are predominantly the result of male-to-male aggressive contacts. AIDS Res Hum Retroviruses 1998, 14:785-796.
15. Fultz P.N., Gordon T.P., Anderson D.C., McClure H.M. Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys. AIDS 1990, 4:619-625.
16. Lackner A.A., Veazey R.S. Current concepts in AIDS pathogenesis: Insights from the SIV/macaque model. Annu Rev Med 2007, 58:461.
17. Souquiere S., Bibollet-Ruche F., Robertson D.L., Makuwa M., Apetrei C., Onanga R., et al. Wild Mandrillus sphinx are carriers of two types of lentivirus. J Virol 2001, 75:7086-7096.
18. Müller M.C., Saksena N.K., Nerrienet E., Chappey C., Herve V.M., Durand J.P., et al. Simian immunodeficiency viruses from central and western Africa: Evidence for a new species-specific lentivirus in tantalus monkeys. J Virol 1993, 67:1227-1235.
19. Pandrea I., Apetrei C., Dufour J., Dillon N., Barbercheck J., Metzger M., et al. Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: A new model for the study of SIV pathogenesis in natural hosts. J Virol 2006, 80:4858-4867.
20. Otsyula M.G., Gettie A., Suleman M., Tarara R., Mohamed I., Marx P. Apparent lack of vertical transmission of simian immunodeficiency virus (SIV) in naturally infected African green monkeys, Cercopithecus aethiops. Ann Trop Med Parasitol 1995, 89:573-576.
21. Santiago M.L., Rodenburg C.M., Kamenya S., Bibollet-Ruche F., Gao F., Bailes E., et al. SIVcpz in wild chimpanzees. Science 2002, 295:465.
22. Sharp P.M., Shaw G.M., Hahn B.H. Simian immunodeficiency virus infection of chimpanzees. J Virol 2005, 79:3891.
23. Rudicell R.S., Holland Jones J., Wroblewski E.E., Learn G.H., Li Y., Robertson J.D., et al. Impact of simian immunodeficiency virus infection on chimpanzee population dynamics. PLoS Pathog 2010, 6. e1001116.
24. Bibollet-Ruche F., Decker J.M., Li Y., Easlick J.L., Kutsch O., Keele B.F., et al. A chimpanzee CD4 glycosylation site polymorphism governs susceptibility to SIVcpz infection 2011, Paper presented at the Keystone Symposia: HIV Evolution, Genomics and Pathogenesis, Whistler, British Columbia, Canada.
25. Corbet S., Müller-Trutwin M.C., Versmisse P., Delarue S., Ayouba A., Lewis J., et al. env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area. J Virol 2000, 74:529-534.
26. Bibollet-Ruche F., Galat-Luong A., Cuny G., Sarni-Manchado P., Galat G., Durand J.P., et al. Simian immunodeficiency virus infection in a patas monkey (Erythrocebus patas): evidence for cross-species transmission from African green monkeys (Cercopithecus aethiops sabaeus) in the wild. J Gen Virol 1996, 77:773-781.
27. Jin M.J., Rogers J., Phillips-Conroy J.E., Allan J.S., Desrosiers R.C., Shaw G.M., et al. Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: Evidence for cross-species transmission in the wild. J Virol 1994, 68:8454-8460.
28. van Rensburg E.J., Engelbrecht S., Mwenda J., Laten J.D., Robson B.A., Stander T., et al. Simian immunodeficiency viruses (SIVs) from eastern and southern Africa: Detection of a SIVagm variant from a chacma baboon. J Gen Virol 1998, 79:1809-1814.
29. Müller-Trutwin M.C., Corbet S., Tavares M.D., Herve V.M., Nerrienet E., Georges-Courbot M.C., et al. The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivo. Virology 1996, 223:89-102.
30. Apetrei C., Gaufin T., Gautam R., Vinton C., Hirsch V., Lewis M., et al. Pattern of SIVagm infection in patas monkeys suggests that host adaptation to simian immunodeficiency virus infection may result in resistance to infection and virus extinction. J Infect Dis 2010, 202(Suppl. 3):S371-S376.
31. Barnett S.W., Murthy K.K., Herndier B.G., Levy J.A. An AIDS-like condition induced in baboons by HIV-2. Science 1994, 266:642-646.
32. Pandrea I., Gautam R., Ribeiro R., Brenchley J.M., Butler I.F., Pattison M., et al. Acute loss of intestinal CD4+ T cells is not predictive of SIV virulence. J Immunol 2007, 179:3035-3046.
33. Beer B.E., Brown C.R., Whitted S., Goldstein S., Goeken R., Plishka R., et al. Immunodeficiency in the absence of high viral load in pig-tailed macaques infected with simian immunodeficiency virus SIVsun or SIVlhoest. J Virol 2005, 79:14044-14056.
34. Hirsch V.M., Dapolito G., Johnson P.R., Elkins W.R., London W.T., Montali R.J., et al. Induction of AIDS by simian immunodeficiency virus from an African green monkey: Species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol 1995, 69:955-967.
35. Favre D., Lederer S., Kanwar B., Ma Z.M., Proll S., Kasakow Z., et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 2009, 5:e1000295.
36. Goldstein S., Ourmanov I., Brown C.R., Plishka R., Buckler-White A., Byrum R., et al. Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: Variable pathogenicity of natural SIVagm isolates. J Virol 2005, 79:5153-5162.
37. Gautam R., Carter A.C., Katz N., Butler I.F., Barnes M., Hasegawa A., et al. In vitro characterization of primary SIVsmm isolates belonging to different lineages. In vitro growth on rhesus macaque cells is not predictive for in vivo replication in rhesus macaques. Virology 2007, 362:257.
38. Apetrei C., Kaur A., Lerche N.W., Metzger M., Pandrea I., Hardcastle J., et al. Molecular epidemiology of simian immunodeficiency virus SIVsm in US Primate Centers unravels the origin of SIVmac and SIVstm. J. Virol 2005, 79:8991-9005.
39. Valli P.J., Goudsmit J. Structured-tree topology and adaptive evolution of the simian immunodeficiency virus SIVsm envelope during serial passage in rhesus macaques according to likelihood mapping and quartet puzzling. J Virol 1998, 72:3673.
40. Apetrei C., Lerche N.W., Pandrea I., Gormus B., Silvestri G., Kaur A., et al. Kuru experiments triggered the emergence of pathogenic SIVmac. AIDS 2006, 20:317-321.
41. Apetrei C., Gautam R., Sumpter B., Carter A.C., Gaufin T., Staprans S.I., et al. Virus subtype-specific features of natural simian immunodeficiency virus SIVsmm infection in sooty mangabeys. J Virol 2007, 81:7913-7923.
42. Diop O.M., Gueye A., Dias-Tavares M., Kornfeld C., Faye A., Ave P., et al. High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J Virol 2000, 74:7538-7547.
43. Onanga R., Kornfeld C., Pandrea I., Estaquier J., Souquiere S., Rouquet P., et al. High levels of viral replication contrast with only transient changes in CD4(+) and CD8(+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in. Mandrillus sphinx. J Virol 2002, 76:10256-10263.
44. Reimann K.A., Tenner-Racz K., Racz P., Montefiori D.C., Yasutomi Y., Lin W., et al. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 1994, 68:2362-2370.
45. Pandrea I., Silvestri G., Onanga R., Veazey R.S., Marx P.A., Hirsch V., et al. Simian immunodeficiency viruses replication dynamics in African non-human primate hosts: Common patterns and species-specific differences. J Med Primatol 2006, 35:194-201.
46. Onanga R., Souquiere S., Makuwa M., Mouinga-Ondeme A., Simon F., Apetrei C., et al. Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx). J Virol 2006, 80:3301-3309.
47. Rey-Cuille M.A., Berthier J.L., Bomsel-Demontoy M.C., Chaduc Y., Montagnier L., Hovanessian A.G., et al. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol 1998, 72:3872-3886.
48. ten Haaft P., Murthy K., Salas M., McClure H., Dubbes R., Koornstra W., et al. Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees. AIDS 2001, 15:2085-2092.
49. Broussard S.R., Staprans S.I., White R., Whitehead E.M., Feinberg M.B., Allan J.S. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J Virol 2001, 75:2262-2275.
50. Goldstein S., Brown C.R., Ourmanov I., Pandrea I., Buckler-White A., Erb C., et al. Comparison of simian immunodeficiency virus SIVagmVer replication and CD4+ T-cell dynamics in vervet and sabaeus African green monkeys. J Virol 2006, 80:4868-4877.
51. Kornfeld C., Ploquin M.J., Pandrea I., Faye A., Onanga R., Apetrei C., et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 2005, 115:1082-1091.
52. Pandrea I., Kornfeld C., Ploquin M.J., Apetrei C., Faye A., Rouquet P., et al. Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol 2005, 79:6249-6259.
53. Liovat A.S., Jacquelin B., Ploquin M.J., Barre-Sinoussi F., Müller-Trutwin M.C. African non human primates infected by SIV-why don't they get sick? Lessons from studies on the early phase of non-pathogenic SIV infection. Curr HIV Res 2009, 7:39-50.
54. Pandrea I., Apetrei C., Gordon S., Barbercheck J., Dufour J., Bohm R., et al. Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts. Blood 2007, 109:1069-1076.
55. Gordon S.N., Dunham R.M., Engram J.C., Estes J., Wang Z., Klatt N.R., et al. Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: Implications for AIDS pathogenesis. J Virol 2008, 82:3725-3735.
56. Chakrabarti L.A., Lewin S.R., Zhang L., Gettie A., Luckay A., Martin L.N., et al. Age-dependent changes in T cell homeostasis and SIV load in sooty mangabeys. J Med Primatol 2000, 29:158-165.
57. Beer B., Denner J., Brown C.R., Norley S., zur Megede J., Coulibaly C., et al. Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:210-220.
58. Chen Z., Gettie A., Ho D.D., Marx P.A. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: A comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Virology 1998, 246:113-124.
59. Deng H.K., Unutmaz D., KewalRamani V.N., Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997, 388:296-300.
60. Riddick N.E., Hermann E.A., Loftin L.M., Elliott S.T., Wey W.C., Cervasi B., et al. A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo. PLoS Pathog 2010, 6. e1001064.
61. Pandrea I., Onanga R., Souquiere S., Mouinga-Ondeme A., Bourry O., Makuwa M., et al. Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding. J Virol 2008, 82:5501-5509.
62. Klatt N.R., Villinger F., Bostik P., Gordon S.N., Pereira L., Engram J.C., et al. Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys. J Clin Invest 2008, 118:2039.
63. Veazey R.S., Lackner A.A. HIV swiftly guts the immune system. Nat Med 2005, 11:469.
64. Zeitz M., Ullrich R., Schneider T., Kewenig S., Riecken E. Mucosal immunodeficiency in HIV/SIV infection. Pathobiology 1998, 66:151-157.
65. Gordon S.N., Klatt N.R., Bosinger S.E., Brenchley J.M., Milush J.M., Engram J.C., et al. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J Immunol 2007, 179:3026-3034.
66. Chakrabarti L.A., Lewin S.R., Zhang L., Gettie A., Luckay A., Martin L.N., et al. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J Virol 2000, 74:1209-1223.
67. Milush J.M., Reeves J.D., Gordon S.N., Zhou D., Muthukumar A., Kosub D.A., et al. Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host. J Immunol 2007, 179:3047-3056.
68. Milush J.M., Mir K.D., Sundaravaradan V., Gordon S.N., Engram J., Cano C.A., et al. Lack of clinical AIDS in SIV-infected sooty mangabeys with significant CD4+ T cell loss is associated with double-negative T cells. J Clin Invest 2011, in press.
69. Beaumier C.M., Harris L.D., Goldstein S., Klatt N.R., Whitted S., McGinty J., et al. CD4 downregulation by memory CD4+ T cells in vivo renders African green monkeys resistant to progressive SIVagm infection. Nat Med 2009, 15:879.
70. Murayama Mukai, Inoue M., Yoshikawa An African green monkey lacking peripheral CD4 lymphocytes that retains helper T cell activity and coexists with SIVagm. Clin Exp Immunol 1999, 117:504.
71. Meythaler M., Martinot A., Wang Z., Pryputniewicz S., Kasheta M., Ling B., et al. Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection. J Virol 2009, 83:572-583.
72. Monceaux V., Viollet L., Petit F., Cumont M.C., Kaufmann G.R., Aubertin A.M., et al. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques. J Virol 2007, 81:13865-13875.
73. Okoye A., Meier-Schellersheim M., Brenchley J.M., Hagen S.I., Walker J.M., Rohankhedkar M., et al. Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 2007, 204:2171-2185.
74. Goldstein S., Ourmanov I., Brown C.R., Beer B.E., Elkins W.R., Plishka R., et al. Wide range of viral load in healthy African green monkeys naturally infected with simian immunodeficiency virus. J Virol 2000, 74:11744-11753.
75. Ploquin M.J., Diop O.M., Sol-Foulon N., Mortara L., Faye A., Soares M.A., et al. DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm. J Virol 2004, 78:798-810.
76. Gueye A., Diop O.M., Ploquin M.J., Kornfeld C., Faye A., Cumont M.C., et al. Viral load in tissues during the early and chronic phase of non-pathogenic SIVagm infection. J Med Primatol 2004, 33:83-97.
77. Beer B., Scherer J., Megede J.Z., Norley S., Baier M., Kurth R. Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys. Virology 1996, 219:367.
78. Cumont M.C., Diop O., Vaslin B., Elbim C., Viollet L., Monceaux V., et al. Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J Virol 2008, 82:1175-1184.
79. Estes J.D., Gordon S.N., Zeng M., Chahroudi A.M., Dunham R.M., Staprans S.I., et al. Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques. J Immunol 2008, 180:6798-6807.
80. Chakrabarti L., Cumont M.C., Montagnier L., Hurtrel B. Variable course of primary simian immunodeficiency virus infection in lymph nodes: Relation to disease progression. J Virol 1994, 68:6634-6643.
81. Meythaler M., Wang Z., Martinot A., Pryputniewicz S., Kasheta M., McClure H.M., et al. Early induction of polyfunctional simian immunodeficiency virus (SIV)-specific T lymphocytes and rapid disappearance of SIV from lymph nodes of sooty mangabeys during primary infection. J Immunol 2011, 186:5151-5161.
82. Pantaleo G., Graziosi C., Demarest J.F., Butini L., Montroni M., Fox C.H., et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362:355-358.
83. Paiardini M., Cervasi B., Reyes-Aviles E., Micci L., Ortiz A.M., Chahroudi A., et al. Low levels of SIV infection in sooty mangabey central memory CD4+ T cells are associated with limited CCR5 expression. Nat Med 2011, 17:830.
84. Deeks S.G., Kitchen C.M., Liu L., Guo H., Gascon R., Narvaez A.B., et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004, 104:942-947.
85. Hazenberg M.D., Otto S.A., van Benthem B.H., Roos M.T., Coutinho R.A., Lange J.M., et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003, 17:1881-1888.
86. McMichael A.J., Borrow P., Tomaras G.D., Goonetilleke N., Haynes B.F. The immune response during acute HIV-1 infection: Clues for vaccine development. Nat Rev Immunol 2010, 10:11-23.
87. Hunt P.W., Brenchley J., Sinclair E., McCune Joseph M., Roland M., Page-Shafer K., et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008, 197:126-133.
88. Ensoli B., Bellino S., Tripiciano A., Longo O., Francavilla V., Marcotullio S., et al. Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART. PLoS One 2010, 5. e13540.
89. van Asten L., Danisman F., Otto S.A., Borghans J.A., Hazenberg M.D., Coutinho R.A., et al. Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection. AIDS 2004, 18:1885-1893.
90. Jacquelin B., Mayau V., Targat B., Liovat A.S., Kunkel D., Petitjean G., et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009, 119:3544-3555.
91. Lederer S., Favre D., Walters K.A., Proll S., Kanwar B., Kasakow Z., et al. Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLoS Pathog 2009, 5. e1000296.
92. Bosinger S.E., Li Q., Gordon S.N., Klatt N.R., Duan L., Xu L., et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 2009, 119:3556-3572.
93. Harris L.D., Tabb B., Sodora D.L., Paiardini M., Klatt N.R., Douek D.C., et al. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J Virol 2010, 84:7886-7891.
94. Silvestri G., Sodora D.L., Koup R.A., Paiardini M., O'Neil S.P., McClure H.M., et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003, 18:441.
95. Kaur A., Di Mascio M., Barabasz A., Rosenzweig M., McClure H.M., Perelson A.S., et al. Dynamics of T- and B-lymphocyte turnover in a natural host of simian immunodeficiency virus. J Virol 2008, 82:1084-1093.
96. Wang Z., Metcalf B., Ribeiro R.M., McClure H., Kaur A. Th-1-type cytotoxic CD8+ T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys. J Virol 2006, 80:2771-2783.
97. Abel K., La Franco-Scheuch L., Rourke T., Ma Z.-M., de Silva V., Fallert B., et al. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques. J Virol 2004, 78:841-854.
98. Campillo-Gimenez L., Laforge M., Fay M., Brussel A., Cumont M.C., Monceaux V., et al. Nonpathogenesis of simian immunodeficiency virus infection is associated with reduced inflammation and recruitment of plasmacytoid dendritic cells to lymph nodes, not to lack of an interferon type I response, during the acute phase. J Virol 2010, 84:1838-1846.
99. Diop O.M., Ploquin M.J., Mortara L., Faye A., Jacquelin B., Kunkel D., et al. Plasmacytoid dendritic cell dynamics and alpha interferon production during simian immunodeficiency virus infection with a nonpathogenic outcome. J Virol 2008, 82:5145-5152.
100. Durudas A., Milush J.M., Chen H.L., Engram J.C., Silvestri G., Sodora D.L. Elevated levels of innate immune modulators in lymph nodes and blood are associated with more-rapid disease progression in simian immunodeficiency virus-infected monkeys. J Virol 2009, 83:12229-12240.
101. Mandl J.N., Barry A.P., Vanderford T.H., Kozyr N., Chavan R., Klucking S., et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 2008, 14:1077.
102. Manches O., Bhardwaj N. Resolution of immune activation defines nonpathogenic SIV infection. J Clin Invest 2009, 119:3512.
103. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365.
104. Estes J.D., Harris L.D., Klatt N.R., Tabb B., Pittaluga S., Paiardini M., et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010, 6. e1001052.
105. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999, 5:919.
106. Colonna M., Trinchieri G., Liu Y.-J. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004, 5:1219.
107. Fonteneau J.-F., Larsson M., Beignon A.-S., McKenna K., Dasilva I., Amara A., et al. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 2004, 78:5223-5232.
108. Jaehn P.S., Zaenker K.S., Schmitz J., Dzionek A. Functional dichotomy of plasmacytoid dendritic cells: Antigen-specific activation of T cells versus production of type I interferon. Eur J Immunol 2008, 38:1822-1832.
109. McKenna K., Beignon A.-S., Bhardwaj N. Plasmacytoid dendritic cells: Linking innate and adaptive immunity. J Virol 2005, 79:17.
110. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284:1835-1837.
111. Ansari A.A., Reimann K.A., Mayne A.E., Takahashi Y., Stephenson S.T., Wang R., et al. Blocking of α4β7 gut-homing integrin during acute infection leads to decreased plasma and gastrointestinal tissue viral loads in simian immunodeficiency virus-infected rhesus macaques. J Immunol 2011, 186:1044-1059.
112. Grassi F., Hosmalin A., McIlroy D., Calvez V., Debre P., Autran B. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS 1999, 13:759-766.
113. Soumelis V., Scott I., Gheyas F., Bouhour D., Cozon G., Cotte L., et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 2001, 98:906-912.
114. Lore K., Sonnerborg A., Brostrom C., Goh L.E., Perrin L., McDade H., et al. Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS 2002, 16:683-692.
115. Zimmer M.I., Larregina A.T., Castillo C.M., Capuano S., Falo L.D., Murphey-Corb M., et al. Disrupted homeostasis of Langerhans cells and interdigitating dendritic cells in monkeys with AIDS. Blood 2002, 99:2859-2868.
116. Malleret B., Maneglier B., Karlsson I., Lebon P., Nascimbeni M., Perie L., et al. Primary infection with simian immunodeficiency virus: Plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression. Blood 2008, 112:4598-4608.
117. Brown K.N., Wijewardana V., Liu X., Barratt-Boyes S.M. Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection. PLoS Pathog 2009, 5. e1000413.
118. Wijewardana V., SoloffA.C., Liu X., Brown K.N., Barratt-Boyes S.M. Early myeloid dendritic cell dysregulation is predictive of disease progression in simian immunodeficiency virus infection. PLoS Pathog 2010, 6. e1001235.
119. Altfeld M., Fadda L., Frleta D., Bhardwaj N. DCs and NK cells: Critical effectors in the immune response to HIV-1. Nat Rev Immunol 2011, 11:176-186.
120. Mortara L., Ploquin M.J.Y., Faye A., Scott-Algara D., Vaslin B., Butor C., et al. Phenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes. J Immunol Methods 2006, 308:138.
121. Liu Y.J. IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005, 23:275.
122. Beignon A.S., McKenna K., Skoberne M., Manches O., DaSilva I., Kavanagh D.G., et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005, 115:3265-3275.
123. Lepelley A., Louis S., Sourisseau M., Law H.K., Pothlichet J., Schilte C., et al. Innate sensing of HIV-infected cells. PLoS Pathog 2011, 7. e1001284.
124. Kulkarni S., Martin M.P., Carrington M. The Yin and Yang of HLA and KIR in human disease. Sem Immunol 2008, 20:343.
125. Alter G., Teigen N., Davis B.T., Addo M.M., Suscovich T.J., Waring M.T., et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 2005, 106:3366-3369.
126. Reeves R.K., Gillis J., Wong F.E., Yu Y., Connole M., Johnson R.P. CD16-natural killer cells: Enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 2010, 115:4439-4446.
127. Giavedoni L.D., Velasquillo M.C., Parodi L.M., Hubbard G.B., Hodara V.L. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol 2000, 74:1648-1657.
128. Kaur A., Hale C.L., Ramanujan S., Jain R.K., Johnson R.P. Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. J Virol 2000, 74:8413-8424.
129. Pereira L.E., Johnson R.P., Ansari A.A. Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection. Cell Immunol 2008, 254:10.
130. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu Rev Immunol 2007, 25:297.
131. Motsinger A., Haas D.W., Stanic A.K., Van Kaer L., Joyce S., Unutmaz D. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 2002, 195:869-879.
132. Fleuridor R., Wilson B., Hou R., Landay A., Kessler H., Al-Harthi L. CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology 2003, 108:3.
133. Motsinger A., Azimzadeh A., Stanic A.K., Johnson R.P., Van Kaer L., Joyce S., et al. Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells. J Virol 2003, 77:8153-8158.
134. Sandberg J.K., Fast N.M., Palacios E.H., Fennelly G., Dobroszycki J., Palumbo P., et al. Selective loss of innate CD4+ Vα24 natural killer T cells in human immunodeficiency virus infection. J Virol 2002, 76:7528-7534.
135. Fernandez C.S., Chan A.C., Kyparissoudis K., De Rose R., Godfrey D.I., Kent S.J. Peripheral NKT cells in simian immunodeficiency virus-infected macaques. J Virol 2009, 83:1617-1624.
136. Rout N., Else J.G., Yue S., Connole M., Exley M.A., Kaur A. Heterogeneity in phenotype and function of CD8+ and CD4/CD8 double-negative natural killer T cell subsets in sooty mangabeys. J Med Primatol 2010, 39:224-234.
137. Rout N., Else J.G., Yue S., Connole M., Exley M.A., Kaur A. Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection. PLoS One 2010, 5. e9787.
138. Kosub D.A., Lehrman G., Milush J.M., Zhou D., Chacko E., Leone A., et al. Gamma/delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections. J Virol 2008, 82:1155-1165.
139. Harris L.D., Klatt N.R., Vinton C., Briant J.A., Tabb B., Ladell K., et al. Mechanisms underlying gamma/delta T-cell subset perturbations in SIV-infected Asian rhesus macaques. Blood 2010, 116:4148-4157.
140. Boullier S., Dadaglio G., Lafeuillade A., Debord T., Gougeon M.L. V delta 1 T cells expanded in the blood throughout HIV infection display a cytotoxic activity and are primed for TNF-alpha and IFN-gamma production but are not selected in lymph nodes. J Immunol 1997, 159:3629-3637.
141. Ploquin M.J., Desoutter J.F., Santos P.R., Pandrea I., Diop O.M., Hosmalin A., et al. Distinct expression profiles of TGF-beta1 signaling mediators in pathogenic SIVmac and non-pathogenic SIVagm infections. Retrovirology 2006, 3:37.
142. Bostik P., Watkins M., Villinger F., Ansari A.A. Genetic analysis of cytokine promoters in nonhuman primates: Implications for Th1/Th2 profile characteristics and SIV disease pathogenesis. Clin Dev Immunol 2004, 11:35-44.
143. Brenchley J.M., Paiardini M., Knox K.S., Asher A.I., Cervasi B., Asher T.E., et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008, 112:2826-2835.
144. Lozano Reina J.M., Favre D., Kasakow Z., Mayau V., Nugeyre M.T., Ka T., et al. Gag p27-specific B- and T-cell responses in simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol 2009, 83:2770-2777.
145. Zahn R.C., Rett M.D., Korioth-Schmitz B., Sun Y., Buzby A.P., Goldstein S., et al. Simian immunodeficiency virus (SIV)-specific CD8+ T-cell responses in vervet African green monkeys chronically infected with SIVagm. J Virol 2008, 82:11577-11588.
146. Dunham R., Pagliardini P., Gordon S., Sumpter B., Engram J., Moanna A., et al. The AIDS-resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood 2006, 108:209-217.
147. Zahn R.C., Rett M.D., Li M., Tang H., Korioth-Schmitz B., Balachandran H., et al. Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease. Blood 2010, 115:3070-3078.
148. Kaur A., Alexander L., Staprans S.I., Denekamp L., Hale C.L., McClure H.M., et al. Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection. Eur J Immunol 2001, 31:3207-3217.
149. Kaur A., Grant R.M., Means R.E., McClure H., Feinberg M., Johnson R.P. Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J Virol 1998, 72:9597-9611.
150. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283:857-860.
151. Jin X., Bauer D.E., Tuttleton S.E., Lewin S., Gettie A., Blanchard J., et al. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999, 189:991-998.
152. Schmitz J.E., Zahn R.C., Brown C.R., Rett M.D., Li M., Tang H., et al. Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys. PLoS Pathog 2009, 5. e1000691.
153. Gaufin T., Ribeiro R., Gautam R., Dufour J., Mandell D., Apetrei C., et al. Experimental depletion of CD8+ cells in acutely SIVagm-infected African green monkeys results in increased viral replication. Retrovirology 2010, 7:42.
154. Belkaid Y., Rouse B.T. Natural regulatory T cells in infectious disease. Nat Immunol 2005, 6:353.
155. Epple H.J., Loddenkemper C., Kunkel D., Troeger H., Maul J., Moos V., et al. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 2006, 108:3072-3078.
156. Estes J.D., Li Q., Reynolds, Matthew R., Wietgrefe S., Duan L., Schacker T., et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 2006, 193:703-712.
157. Karlsson I., Malleret B., Brochard P., Delache B., Calvo J., Le Grand R., et al. Suppressive activity of regulatory T cells correlates with high CD4+ T-cell counts and low T-cell activation during chronic simian immunodeficiency virus infection. AIDS 2011, 25:585-593.
158. Li L., Liu Y., Bao Z., Chen L., Wang Z., Li T., et al. Analysis of CD4+CD25+Foxp3+ regulatory T cells in HIV-exposed seronegative persons and HIV-infected persons with different disease progressions. Viral Immunol 2011, 24:57-60.
159. Pereira L.E., Villinger F., Onlamoon N., Bryan P., Cardona A., Pattanapanysat K., et al. Simian immunodeficiency virus (SIV) infection influences the level and function of regulatory T cells in SIV-infected rhesus macaques but not SIV-infected sooty mangabeys. J Virol 2007, 81:4445-4456.
160. Fultz P.N., Stricker R.B., McClure H.M., Anderson D.C., Switzer W.M., Horaist C. Humoral response to SIV/SMM infection in macaque and mangabey monkeys. J Acquir Immune Defic Syndr 1990, 3:319-329.
161. Norley S.G., Kraus G., Ennen J., Bonilla J., Konig H., Kurth R. Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys. Proc Natl Acad Sci USA 1990, 87:9067-9071.
162. Li B., Stefano-Cole K., Kuhrt D.M., Gordon S.N., Else J.G., Mulenga J., et al. Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies. J Virol 2010, 84:6248-6253.
163. Brenchley J.M., Silvestri G., Douek D.C. Nonprogressive and progressive primate immunodeficiency lentivirus infections. Immunity 2010, 32:737.
164. Sodora D.L., Allan J.S., Apetrei C., Brenchley J.M., Douek D.C., Else J.G., et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 2009, 15:861-865.
165. d'Ettorre G., Paiardini M., Ceccarelli G., Silvestri G., Vullo V. HIV-associated immune activation: From bench to bedside. AIDS Res Hum Retroviruses 2011, 27.
166. Schindler M., Münch J., Kutsch O., Li H., Santiago M.L., Bibollet-Ruche F., et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 2006, 125:1055.
167. Schindler M., Schmökel J., Specht A., Li H., Münch J., Khalid M., et al. Inefficient Nef-mediated downmodulation of CD3 and MHC-I correlates with loss of CD4+ T cells in natural SIV infection. PLoS Pathog 2008, 4. e1000107.
168. Meythaler M., Pryputniewicz S., Kaur A. Kinetics of T lymphocyte apoptosis and the cellular immune response in SIVmac239-infected rhesus macaques. J Med Primatol 2008, 37:33.
169. Ameisen J., Capron A. Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis. Immunol Today 1991, 12:102.
170. Estaquier J., Idziorek T., de Bels F., Barre-Sinoussi F., Hurtrel B., Aubertin A.M., et al. Programmed cell death and AIDS: Significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci USA 1994, 91:9431-9435.
171. Gougeon M.L., Garcia S., Heeney J., Tschopp R., Lecoeur H., Guetard D., et al. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 1993, 9:553-563.
172. Herbeuval J.-P., Shearer G.M. HIV-1 immunopathogenesis: How good interferon turns bad. Clin Immunol 2007, 123:121.
173. Gasper-Smith N., Crossman D.M., Whitesides J.F., Mensali N., Ottinger J.S., Plonk S.G., et al. Induction of plasma (TRAIL), TNFR-2, fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: Implications for HIV-1 vaccine design. J Virol 2008, 82:7700-7710.
174. Harris L.D., Tabb B., Sodora D.L., Paiardini M., Klatt N.R., Douek D.C., et al. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J Virol 2010, 84:7886-7891.
175. Foley J.F., Yu C.-R., Solow R., Yacobucci M., Peden K.W.C., Farber J.M. Roles for CXC chemokine ligands 10 and 11 in recruiting CD4+ T cells to HIV-1-infected monocyte-derived macrophages, dendritic cells, and lymph nodes. J Immunol 2005, 174:4892-4900.
176. Lacotte S., Brun S., Muller S., Dumortier H. CXCR3, inflammation, and autoimmune diseases. Ann NY Acad Sci 2009, 1173:310-317.
177. Stacey A.R., Norris P.J., Qin L., Haygreen E.A., Taylor E., Heitman J., et al. Induction of a striking systemic cytokine cascade prior to peak viraemia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009, 3719-3733.
178. Li Q., Skinner P.J., Ha S.-J., Duan L., Mattila T.L., Hage A., et al. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 2009, 323:1726-1729.
179. Beer B.E., Bailes E., Goeken R., Dapolito G., Coulibaly C., Norley S.G., et al. Simian immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): Evidence for host-dependent evolution of SIV within the C. l'hoesti superspecies. J Virol 1999, 73:7734-7744.
180. Lernould J. Classification and geographical distribution of guenons: A review. A Primate Radiation: Evolutionary Biology of the African Guenons 1988, 78. Cambridge University Press, Cambridge. A. Gautier-Hion, F. Boulière, J. Gautier, J. Kingdon (Eds.).
181. Sharp P.M., Hahn B.H. The evolution of HIV-1 and the origin of AIDS. Phil Trans R Soc B Biol Sci 2010, 365:2487.